Sign inJoin waitlistJoin the waitlist

Larry Cripe

Professor of Medicine · Indiana University School of Medicine

Credentials: · · ·

History

Indiana University School of Medicine
Present

Hematology and Medical Oncology
Duke University Hospital
1987–1990
Rush Presbyterian St. Luke Medical Center
1984–1987
Rush Medical College
1980–1984

Research

BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein
Cell · 1993 · 625 citations
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Blood · 2010 · 618 citations
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma
Journal of Clinical Oncology · 2002 · 482 citations

MT
Martin Tallman
24 papers
Mark Litzow
14 papers
Hillard Lazarus
10 papers
Hugo Fernandez
10 papers
Hamid Sayar
8 papers
Selina Luger
8 papers
HB
Howard Boswell
7 papers
John Bennett
7 papers
PW
Peter Wiernik
7 papers
DD
Dan Douer
5 papers
Rhett Ketterling
5 papers
Attaya Suvannasankha
4 papers

Grants

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $82.2K · Indiana University Indianapolis
2004–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $775 · Indiana University Indianapolis
2005–2008

Clinical trials

Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
Study chair · Terminated · Phase 2
Larry Cripe, MD
2006–2008
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Study chair · Completed · Phase 3
Eastern Cooperative Oncology Group
2002
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
Site PI · Unknown · Phase 1
Cambridge Antibody Technology
2007